Shanxi Zhendong Pharmaceutical Total Liabilities
Shanxi Zhendong Pharmaceutical total liabilities. Based on the latest financial reports, Shanxi Zhendong Pharmaceutical (300158) has total liabilities worth CN¥882.65 Million CNY (≈ $129.16 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shanxi Zhendong Pharmaceutical (300158) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shanxi Zhendong Pharmaceutical (2007–2024)
Total liabilities of Shanxi Zhendong Pharmaceutical from 2007 to 2024. This chart illustrates how Shanxi Zhendong Pharmaceutical's total liabilities have evolved over time, based on quarterly financial data. Explore Shanxi Zhendong Pharmaceutical strategic investment ratio to see how much of total assets are deployed in long-term investments.
Shanxi Zhendong Pharmaceutical Competitors by Total Liabilities
The table below lists competitors of Shanxi Zhendong Pharmaceutical ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AhnLab Inc
KQ:053800
|
Korea | ₩139.78 Billion |
|
Tainan Spinning Co Ltd
TW:1440
|
Taiwan | NT$17.44 Billion |
|
Shanghai Maling Aquarius Co Ltd
SHG:600073
|
China | CN¥8.51 Billion |
|
Mrs. Bectors Food Specialities Limited
NSE:BECTORFOOD
|
India | Rs4.16 Billion |
|
AGF Management Limited
F:A3J
|
Germany | €527.47 Million |
|
Beingmate Baby & Child Food Co Ltd
SHE:002570
|
China | CN¥1.98 Billion |
|
First Watch Restaurant Group Inc
NASDAQ:FWRG
|
USA | $1.19 Billion |
|
ITE Tech Inc
TW:3014
|
Taiwan | NT$2.16 Billion |
Liability Composition Analysis (2007–2024)
This chart breaks down Shanxi Zhendong Pharmaceutical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300158 total assets.
Liquidity & Leverage Metrics
Shanxi Zhendong Pharmaceutical Total Liabilities Ratios Explained
Shanxi Zhendong Pharmaceutical total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanxi Zhendong Pharmaceutical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanxi Zhendong Pharmaceutical (2007–2024)
The table below shows the annual total liabilities of Shanxi Zhendong Pharmaceutical from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.32 Billion ≈ $193.52 Million |
+27.60% |
| 2023-12-31 | CN¥1.04 Billion ≈ $151.66 Million |
-21.94% |
| 2022-12-31 | CN¥1.33 Billion ≈ $194.27 Million |
-34.89% |
| 2021-12-31 | CN¥2.04 Billion ≈ $298.37 Million |
+3.50% |
| 2020-12-31 | CN¥1.97 Billion ≈ $288.27 Million |
+33.64% |
| 2019-12-31 | CN¥1.47 Billion ≈ $215.71 Million |
-20.32% |
| 2018-12-31 | CN¥1.85 Billion ≈ $270.73 Million |
-10.00% |
| 2017-12-31 | CN¥2.06 Billion ≈ $300.82 Million |
+28.24% |
| 2016-12-31 | CN¥1.60 Billion ≈ $234.57 Million |
-21.42% |
| 2015-12-31 | CN¥2.04 Billion ≈ $298.52 Million |
+129.67% |
| 2014-12-31 | CN¥888.23 Million ≈ $129.98 Million |
+5.91% |
| 2013-12-31 | CN¥838.64 Million ≈ $122.72 Million |
+22.56% |
| 2012-12-31 | CN¥684.26 Million ≈ $100.13 Million |
+72.18% |
| 2011-12-31 | CN¥397.40 Million ≈ $58.15 Million |
+2.13% |
| 2010-12-31 | CN¥389.13 Million ≈ $56.94 Million |
+37.08% |
| 2009-12-31 | CN¥283.87 Million ≈ $41.54 Million |
+23.43% |
| 2008-12-31 | CN¥229.98 Million ≈ $33.65 Million |
-20.77% |
| 2007-12-31 | CN¥290.28 Million ≈ $42.48 Million |
-- |
About Shanxi Zhendong Pharmaceutical
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is b… Read more